Daily Market Commentary

April 13, 2021

Bonds & Stocks
The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson's shot after six women who received it developed a rare and severe form of blood clotting.

U.S. consumer prices climbed in March by more than forecast, adding to evidence of budding inflationary pressures as the economy reopens and demand strengthens.

China's trade jumped in March, a sign that the global recovery from the Covid-19 pandemic is well on track as vaccine rollouts around the world pick up pace.

The information represented herein was obtained from various sources, which we believe to be reliable, Neither the information presented nor opinions expressed constitutes an offer to buy or sell any security. And it is not intended to guide the investor on which securities to buy, or when to buy or sell.

Today, Tomorrow, Together